I am a healthcare professional
If you are a healthcare professional looking to find out more about heavy menstrual bleeding and contraception, please click below.
If you are not a healthcare professional and you want to learn about contraception please click below.
If you are not a healthcare professional and you want to learn about heavy menstural bleedingplease click below.
HCP

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

Bayer logo

Welcome to Women's Health Matters, an online resource to support healthcare professionals involved in the area of Women's Health.

How can Kyleena® (19.5mg levonorgestrel IUS) support optimisation of your service?

This promotional meeting is part of the Women’s Health Matters Educational Programme that is organised and fully funded by Bayer

Feb 12 2020 | 19:30 - 20:30

Recorded: Feb 12 2020 | 19:30 - 20:30

Duration Time:

This webinar is part of the “Women’s Health Matters” Medical Educational programme which aims to inspire, update and support healthcare professionals with an interest in women’s health.

A letter of attendance for 1 hour of medical education will be available for attendees completing the webinar.
 

The webinar will provide an evidence-based update on:

How can Kyleena®(19.5mg levonorgestrel IUS) support optimisation of your service?

  • Overview of Kyleena
  • Understanding of FSRH guidance on Intrauterine systems
  • Insights into the Manchester experience of Kyleena, including cases studies to share best practice
  • Insights into the Leeds experience of Kyleena with hints, tips and tools for counselling

Full programme

Speakers

Pic

Dr Asha Kasliwal

Clinical Director and Consultant in Community Gynaecology & Reproductive Healthcare

Manchester

Dr Asha Kasliwal is the President of the Faculty of Sexual and Reproductive Healthcare (FSRH) of the Royal College of Obstetricians and Gynaecologists (RCOG). As President, she is able to combine her passion for women’s health with the opportunity to influence on a national platform. She is based in Manchester and works as a Consultant in Community Gynaecology and Reproductive Healthcare and Clinical lead for the citywide contraceptive and community gynaecology service.

Dr Kasliwal has driven an ambitious modernisation programme in Manchester and has championed multidisciplinary working with medical support to extend the role of nurses.

Dr Kasliwal’s areas of expertise include community gynaecology, quality of care and clinical standards, support for commissioning contraception and sexual health services, menopause and hormone replacement therapy. She has been a specialist member on the NICE committees which published Quality Standards for ‘Contraceptive Services’ and ‘Sexual Health’.

Pic

Dr Farah Chaudhry

Consultant in Sexual and Reproductive Health in Leeds Community Healthcare NHS Trust

Yorkshire

I returned home to Yorkshire having studied in Cambridge and completing my training in London. I worked as a GP in Leeds for 10 years with an interest in Women’s Health which subsequently evolved into a full-time career in SRH. I have had a varied career, having had worked as Consultant SRH and Contraceptive lead at Salford Royal, Bradford & Kirklees Sexual Health services and surgeon for BPAS. I am delighted to now be working as Consultant SRH for Leeds Sexual Health, in my home-town. 

Throughout my practice I have maintained an interest and passion for training and development. I have been CEU Guideline Fellow, Joint Faculty Regional Training Advisor for Yorkshire & Humber, General Training Programme Director, MFSRH Examiner and SAS Tutor.

eventform

Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at www.yellowcard.mhra.gov.uk. Adverse events should also be reported to Bayer plc Tel: 01182063500, Fax: 01182063703, Email: pvuk@bayer.com.


If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: qualitycomplaints@bayer.com For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.

  • PP-PF-WHC-GB-0506 August 2020

Copyright © 2019,
Bayer plc

This website is intended for UK healthcare professionals only. Women’s Health Matters is organised and funded by Bayer and contains promotional content.

Prescribing Information (PI) can be found via the links below:
Mirena® (52 mg intrauterine delivery system Levonorgestrel)
Kyleena® (19.5 mg intrauterine delivery system Levonorgestrel)
Jaydess® (13.5 mg intrauterine delivery system Levonorgestrel)
Qlaira® (estradiol valerate/dienogest)
Microgynon® (levonorgestrel/ethinylestradiol)

Page last modified Thu, 11/19/2020 - 12:00

Bayer logo